What is the long-term trend for Merck & Co.'s finite-lived intangible assets - expected amortization expense (year two)?

Over 3 years (2022 to 2025), Merck & Co.'s finite-lived intangible assets - expected amortization expense (year two) has grown at a 40.4% compound annual growth rate (CAGR), from $1.30B to $3.60B.

Discontinued — last reported Q3 '20

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Two)

Non-Current Assets

Merck & Co. Finite-Lived Intangible Assets - Expected Amortization Expense (Year Two) increased by 71.4% to $3.60B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year Two) shows an upward trend with a 40.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryProfitability

SignalLower is better

VolatilityStable

First reportedQ1 2016

Last reportedQ3 2020

How to read this metric

Consistent or declining amortization schedules provide predictability for future earnings, whereas spikes may indicate large, recent asset acquisitions.

Detailed definition

This is the projected expense for the second year following the balance sheet date related to the systematic write-down...

Peer comparison

Standard forward-looking disclosure used by analysts to build multi-year financial models and earnings projections.

Metric ID: finite_lived_intangible_assets_amortization_year_2

Historical Data

4 periods

	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$1.30B	$1.40B	$2.10B	$3.60B
QoQ Change	—	+7.7%	+50.0%	+71.4%
YoY Change	—	+7.7%	+50.0%	+71.4%

Range$1.30B – $3.60B

Avg YoY Growth+43.0%

Median YoY Growth+50.0%

Current Streak3+ quarters growth

Frequently Asked Questions

What is Merck & Co.'s finite-lived intangible assets - expected amortization expense (year two)?: Merck & Co. (MRK) reported finite-lived intangible assets - expected amortization expense (year two) of $3.60B in Q4 2025.
What is the long-term trend for Merck & Co.'s finite-lived intangible assets - expected amortization expense (year two)?: Over 3 years (2022 to 2025), Merck & Co.'s finite-lived intangible assets - expected amortization expense (year two) has grown at a 40.4% compound annual growth rate (CAGR), from $1.30B to $3.60B.
What does finite-lived intangible assets - expected amortization expense (year two) mean?: The expected accounting expense for writing down intangible assets in the second year.